Thynk Capital
Historical Investment Performance in Top 1% of Venture Funds. Primary focus on Longevity and defeating Diseases of Aging.
Business Model:
Revenue: $0
Employees: 0-0
Rankings
Industries / Tags:
Detailed Thynk Capital Information
Geographic Data
Address:
City:
State:
Zip:
Country:
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Facebook
Linkedin
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Thynk Capital possess a historical investment performance in the top 1% of venture capital. Focused on investments in early stage pharma and biotech companies focused on extending HealthSpan and major diseases of Aging including Alzheimer&s;s, Dementia, Kidney Disease, Cancer, Cardiovascular, Diabetes, Frailty, and Rare Disease which affect over 25% of the population and growing at 10%/year.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 11/2017 | X4 Pharmaceuticals | Series A | - |
| 4/2019 | Repair Biotechnologies | Convertible Note | - |
| 6/2018 | KitoTech Medical | Convertible Note | - |
| 2/2015 | WinSanTor, Inc. | Series A | - |
| 7/2016 | Curtana Pharmaceuticals | Convertible Note | - |
| 8/2021 | IMX | Seed Round | - |
| 7/2013 | Lubris BioPharma | Series A | - |
| 3/2021 | iviva medical | Seed Round | - |
| 12/2017 | Theragene Pharmaceuticals | Convertible Note | - |
| 11/2018 | Elicio Therapeutics | Venture Round | - |
| 5/2019 | Viscient Biosciences | Seed Round | - |
| 5/2019 | Repair Biotechnologies | Seed Round | 0 |
| 4/2019 | X-Vax Technology | Series A | - |
| 9/2017 | Fisker | Series A | - |
| 3/2018 | Marina Biotech | Post-IPO Equity | - |
| 11/2017 | KLOTHO Therapeutics, Inc. | Series A | 10M |
| 2/2018 | Elevian | Convertible Note | 2.9M |
| 8/2021 | IMX | Seed Round | - |
| 3/2021 | iviva medical | Seed Round | - |
| 5/2019 | Viscient Biosciences | Seed Round | - |
| 5/2019 | Repair Biotechnologies | Seed Round | 0 |
| 4/2019 | X-Vax Technology | Series A | - |
| 4/2019 | Repair Biotechnologies | Convertible Note | - |
| 11/2018 | Elicio Therapeutics | Venture Round | - |
| 6/2018 | KitoTech Medical | Convertible Note | - |
| 3/2018 | Marina Biotech | Post-IPO Equity | - |
| 2/2018 | Elevian | Convertible Note | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
